Pushing the Boundaries of Science
Our research and development is fueled by a relentless sense of urgency and an steadfast commitment to helping more rare disease patients and their families around the world.
Learn how we are addressing some of today’s most pressing rare disease challenges by in...
Pushing the Boundaries of Science
Our research and development is fueled by a relentless sense of urgency and an steadfast commitment to helping more rare disease patients and their families around the world.
Learn how we are addressing some of today’s most pressing rare disease challenges by investigating in new targets, modalities and technologies, with more opportunities for innovation than ever before. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs.
Alexio
This website and its content are protected by international copyright laws. Unauthorized
use, reproduction, or distribution is prohibited.
We use essential cookies to make our platform work properly. With your consent, we also use limited
analytics cookies to understand site usage (e.g., number of visits). Without your consent, our default
cookie settings will apply.
Privacy Policy.
121 Seaport Blvd
Boston, Massachusetts, US 
11888345678
